Cell Signaling & Signal Transduction
Cells do not exist in isolation—they constantly communicate. This final unit reveals the elegant molecular conversations that cells conduct using chemical signals. You will study the diverse receptor types that detect these signals, trace the intricate intracellular signaling cascades (like the MAP Kinase pathway) that relay the message to the nucleus, understand how Protein Kinases act as molecular switches via phosphorylation, and critically analyze how misregulation of these pathways drives devastating diseases like cancer.
Syllabus & Topics
- 1Cell Signals: Introduction: Cells communicate through chemical signals (ligands) that bind to specific receptors. Types of Signaling: Autocrine: Cell signals ITSELF (e.g., T-cell activation). Paracrine: Cell signals NEARBY cells (e.g., neurotransmitters crossing a synapse). Endocrine: Cell signals DISTANT cells via hormones transported through the bloodstream (e.g., Insulin from the Pancreas acting on Liver cells). Juxtacrine: Requires direct cell-to-cell physical contact (e.g., Notch signaling). Signal Molecules (Ligands): can be proteins, peptides, amino acids, nucleotides, steroids, fatty acid derivatives, or even dissolved gases (like Nitric Oxide).
- 2Receptors for Cell Signals: Cell Surface Receptors (for large, water-soluble ligands that CANNOT cross the membrane): (1) G-Protein Coupled Receptors (GPCRs): The largest family. 7-transmembrane domain proteins that activate intracellular G-proteins (Gs, Gi, Gq), which then modulate second messengers (cAMP, IP3, DAG, Ca²⁺). (2) Receptor Tyrosine Kinases (RTKs): Upon ligand binding (e.g., EGF, Insulin), they dimerize and auto-phosphorylate their intracellular tyrosine residues, triggering downstream cascades. (3) Ligand-Gated Ion Channels: Open or close ion channels directly upon ligand binding. Intracellular Receptors (for small, lipid-soluble ligands like steroid hormones that CAN cross the membrane and bind nuclear receptors to directly regulate gene transcription).
- 3Signaling Pathways: Overview: The Ras-Raf-MEK-ERK (MAP Kinase) Pathway: A crucial cascade for cell growth and proliferation. (1) A growth factor (like EGF) binds its RTK receptor. (2) Receptor dimerizes and autophosphorylates. (3) Adaptor protein (Grb2/SOS) recruits and activates Ras (a small GTPase) by exchanging GDP for GTP. (4) Active Ras activates Raf (a kinase). (5) Raf phosphorylates MEK. (6) MEK phosphorylates ERK. (7) Activated ERK enters the nucleus and phosphorylates transcription factors, turning ON genes for cell division. Second Messenger Systems: cAMP Pathway (activated by GPCRs via Adenylyl Cyclase), Calcium/IP3 Pathway (activated via Phospholipase C).
- 4Misregulation of Signaling Pathways: When the precisely calibrated signaling machinery malfunctions, catastrophic diseases result. Oncogenes: Mutated versions of normal signaling genes (proto-oncogenes) that become permanently ‘stuck ON’. Example: Mutant Ras (found in ~30% of ALL human cancers). A single point mutation prevents Ras from hydrolyzing GTP back to GDP, making it constitutively active, permanently sending ‘DIVIDE!’ signals to the nucleus regardless of external growth factors. Tumor Suppressors: Genes encoding proteins that BRAKE cell growth (like p53, Rb). When these mutate and LOSE function, the brakes are removed, and cells divide uncontrollably. Therapeutic Targets: Many modern anticancer drugs (Imatinib, Erlotinib, Trastuzumab) specifically target these misregulated signaling proteins.
- 5Protein Kinases: Functioning: Protein Kinases are the fundamental molecular switches of cell signaling. They catalyze the transfer of a phosphate group from ATP to a specific amino acid residue on a target protein (Phosphorylation). Types by Target Residue: Serine/Threonine Kinases (e.g., Raf, MEK, PKC): Phosphorylate -OH groups on Serine or Threonine residues. Tyrosine Kinases (e.g., RTKs like EGFR, Src): Phosphorylate -OH groups on Tyrosine residues. Dual-Specificity Kinases (e.g., MEK): Can phosphorylate both Threonine and Tyrosine. Protein Phosphatases: The ‘OFF switches’—enzymes that REMOVE the phosphate group, reversing the kinase action and deactivating the protein. Signal Amplification: A single active kinase can phosphorylate hundreds of target molecules, each of which activates hundreds more, creating an exponential amplification cascade from a single initial receptor activation event.
Learning Objectives
Exam Prep Questions
Q1. Why are GPCRs (G-Protein Coupled Receptors) considered the most important drug targets in pharmacy?
GPCRs are the largest class of drug targets, with over 35% of FDA-approved drugs acting on them. They regulate a wide range of essential physiological functions, including heart rate (β-adrenergic receptors), pain perception (opioid receptors), mood (serotonin receptors), allergies (histamine receptors), and blood pressure (angiotensin receptors). Their characteristic 7-transmembrane structure forms an accessible binding pocket on the cell surface, making them highly “druggable” for small molecule drugs.
Q2. How does a single Ras mutation cause cancer?
Ras is a signaling protein that functions as a molecular switch, turning ON when bound to GTP and OFF when it hydrolyzes GTP to GDP. A single point mutation (commonly at codon 12) prevents this GTP hydrolysis. As a result, Ras remains permanently active, continuously sending signals for cell growth and division even in the absence of external stimuli. This uncontrolled signaling leads to excessive cell proliferation and tumor formation.
Q3. What is “Signal Amplification” and why is it biologically important?
Signal amplification is a process where a single signaling molecule triggers a cascade that produces a large cellular response. For example, one hormone molecule binding to a receptor can activate multiple G-proteins, each of which activates enzymes that generate thousands of second messenger molecules like cAMP. These, in turn, activate numerous downstream proteins. This exponential effect allows a very small initial signal to produce a rapid and significant physiological response, such as increasing heart rate or mobilizing energy.